Antimicrobial peptides with cell-penetrating peptide properties and vice versa

Antimicrobial peptides (AMPs) are a group of peptides that are active against a diverse spectrum of microorganisms. Due to their mode of action, AMPs are a promising class of molecules that could overcome the problems of increasing resistance of bacteria to conventional antibiotics. Furthermore, AMPs are strongly membrane-active and some are able to translocate into cells without the necessity for permanent membrane permeabilization. This feature has brought them into focus for use as transport vectors in the context of drug delivery. Since the plasma membrane restricts transport of bioactive substances into cells, great research interest lies in the development of innovative ways to overcome this barrier and to increase bioavailability. In this context, peptide-based transport systems, such as cell-penetrating peptides (CPPs), have come into focus, and their efficiency has been demonstrated in many different applications. However, more recently, also some AMPs have been used as efficient vectors for intracellular translocation of various active molecules. This review summarizes recent efforts in this interesting field of drug delivery. Moreover, some examples of the application of CPPs as efficient antimicrobial substances will be discussed.

[1]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[2]  A. Prochiantz,et al.  The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.

[3]  R. Gust,et al.  Specific labeling with potent radiolabels alters the uptake of cell‐penetrating peptides , 2009, Biopolymers.

[4]  L. Chaloin,et al.  A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. , 1997, Nucleic acids research.

[5]  Laszlo Otvos,et al.  Antibacterial peptides and proteins with multiple cellular targets , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[6]  S. Henriques,et al.  Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. , 2004, Biochemistry.

[7]  K. Hahm,et al.  Biological activity of Tat (47-58) peptide on human pathogenic fungi. , 2006, Biochemical and biophysical research communications.

[8]  H. G. Boman Innate immunity and the normal microflora , 2000, Immunological reviews.

[9]  R. Lehrer,et al.  Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins , 1993, FEBS letters.

[10]  Alan J. Waring,et al.  Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.

[11]  Y. Shai,et al.  Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells* , 2006, Journal of Biological Chemistry.

[12]  S. Shin,et al.  Antimicrobial and Cytolytic Activities and Plausible Mode of Bactericidal Action of the Cell Penetrating Peptide Penetratin and Its Lys‐linked Two‐Stranded Peptide , 2009, Chemical biology & drug design.

[13]  R. Gennaro,et al.  Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins , 1990, Infection and immunity.

[14]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[15]  Christoph Patsch,et al.  The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .

[16]  L. Otvos,et al.  Antibacterial peptides isolated from insects. , 2000, Journal of peptide science : an official publication of the European Peptide Society.

[17]  R. Gennaro,et al.  Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes , 1994, FEBS letters.

[18]  E. Eklund,et al.  The Human Antimicrobial Peptide LL-37 Transfers Extracellular DNA Plasmid to the Nuclear Compartment of Mammalian Cells via Lipid Rafts and Proteoglycan-dependent Endocytosis* , 2004, Journal of Biological Chemistry.

[19]  K. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[20]  M. Przybylski,et al.  Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. , 1990, The Journal of biological chemistry.

[21]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[22]  L. Otvos,et al.  An insect antibacterial peptide-based drug delivery system. , 2004, Molecular pharmaceutics.

[23]  S. White,et al.  Structure, location, and lipid perturbations of melittin at the membrane interface. , 2001, Biophysical journal.

[24]  Rainer Fischer,et al.  A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.

[25]  G. Lindblom,et al.  Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. , 2003, Biophysical journal.

[26]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  M Bolognesi,et al.  Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. , 1988, The Journal of biological chemistry.

[28]  Huey W. Huang,et al.  Action of antimicrobial peptides: two-state model. , 2000, Biochemistry.

[29]  J. Larrick,et al.  Antimicrobial activity of rabbit CAP18-derived peptides , 1993, Antimicrobial Agents and Chemotherapy.

[30]  B. Wiesner,et al.  Structural requirements for cellular uptake of alpha-helical amphipathic peptides. , 1999, Journal of Peptide Science.

[31]  W. Anderson,et al.  Human gene therapy. , 1992, Science.

[32]  J. Wade,et al.  Synthesis of a disulfide-linked octameric peptide construct carrying three different antigenic determinants. , 2001, Bioorganic & medicinal chemistry letters.

[33]  P. Kinnunen,et al.  Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action. , 2006, Biochimica et biophysica acta.

[34]  R. Hancock,et al.  Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. , 2005, Biochemistry.

[35]  Hongliang Lan,et al.  Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. , 2006, Biochemical and biophysical research communications.

[36]  Eric Vives,et al.  Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.

[37]  E Neumann,et al.  Electric field mediated gene transfer. , 1982, Biochemical and biophysical research communications.

[38]  R. Houghten,et al.  Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. , 1991, Biochemistry.

[39]  H. Vogel,et al.  Lactoferricin , 2005, Cellular and Molecular Life Sciences.

[40]  T. Bártfai,et al.  VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. , 2001, Experimental cell research.

[41]  H. Aoyagi,et al.  Interaction of the fragments characteristic of bactenecin 7 with phospholipid bilayers and their antimicrobial activity. , 1995, Journal of biochemistry.

[42]  Ülo Langel,et al.  Cell entry and antimicrobial properties of eukaryotic cell‐ penetrating peptides , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  R. Hancock,et al.  Interaction of Cationic Antimicrobial Peptides with Model Membranes* , 2001, The Journal of Biological Chemistry.

[44]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[45]  R. Gennaro,et al.  Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils , 1989, Infection and immunity.

[46]  R. Hancock,et al.  Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.

[47]  R. Jelinek,et al.  Membrane interactions of host-defense peptides studied in model systems. , 2005, Current protein & peptide science.

[48]  T. Mirzabekov,et al.  Membrane channel formation by antimicrobial protegrins. , 1999, Biochimica et biophysica acta.

[49]  J. Larrick,et al.  The solution structure of the active domain of CAP18 — a lipopolysaccharide binding protein from rabbit leukocytes , 1995, FEBS letters.

[50]  S. Shin,et al.  Effects of dimerization of the cell‐penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[51]  J. Tam,et al.  Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. , 2002, Biochemistry.

[52]  André Pèlegrin,et al.  Cell-penetrating and cell-targeting peptides in drug delivery. , 2008, Biochimica et biophysica acta.

[53]  Karolin F Meyer,et al.  Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. , 2008, Bioconjugate chemistry.

[54]  Ralph Weissleder,et al.  Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.

[55]  N. Fujii,et al.  Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. , 1995, Biochemistry.

[56]  U. Schatzschneider,et al.  Cymantrene conjugation modulates the intracellular distribution and induces high cytotoxicity of a cell-penetrating peptide. , 2008, Chemical communications.

[57]  R I Lehrer,et al.  Antimicrobial peptides in mammalian and insect host defence. , 1999, Current opinion in immunology.

[58]  I. Mäger,et al.  In vivo biodistribution and efficacy of peptide mediated delivery. , 2010, Trends in pharmacological sciences.

[59]  C. Rousselle,et al.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. , 2000, Molecular pharmacology.

[60]  K. Merz,et al.  Influence of the metal complex-to-peptide linker on the synthesis and properties of bioactive CpMn(CO)3 peptide conjugates. , 2010, Dalton transactions.

[61]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[62]  M. Mutter,et al.  Retention behaviour of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns. , 1991, Journal of chromatography.

[63]  B. Rothen‐Rutishauser,et al.  Novel peptide conjugates for tumor-specific chemotherapy. , 2001, Journal of medicinal chemistry.

[64]  Miguel A R B Castanho,et al.  Cell-penetrating peptides and antimicrobial peptides: how different are they? , 2006, The Biochemical journal.

[65]  D. Hultmark,et al.  Sequence and specificity of two antibacterial proteins involved in insect immunity , 1981, Nature.

[66]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[67]  Ű. Langel,et al.  CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[68]  K. Matsuzaki Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[69]  Isabel D. Alves,et al.  Translocation and Endocytosis for Cell-penetrating Peptide Internalization , 2009, The Journal of Biological Chemistry.

[70]  R. Hancock,et al.  The relationship between peptide structure and antibacterial activity , 2003, Peptides.

[71]  Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles. , 2002, Biochemistry.

[72]  Y. Shai,et al.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.

[73]  Ű. Langel,et al.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.

[74]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[75]  Ű. Langel,et al.  Cell-penetrating peptides--a brief introduction. , 2006, Biochimica et biophysica acta.

[76]  T. Bártfai,et al.  Cellular translocation of proteins by transportan , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  R. Hancock,et al.  Interaction and Cellular Localization of the Human Host Defense Peptide LL-37 with Lung Epithelial Cells , 2005, Infection and Immunity.

[78]  S. González-Chávez,et al.  Lactoferrin: structure, function and applications. , 2009, International journal of antimicrobial agents.

[79]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[80]  R. Gust,et al.  Protease-activatable organometal-Peptide bioconjugates with enhanced cytotoxicity on cancer cells. , 2010, Bioconjugate chemistry.

[81]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[82]  Miguel A R B Castanho,et al.  Translocation of beta-galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. , 2005, Biochemistry.

[83]  Ű. Langel,et al.  Cell-penetrating peptides: mechanisms and applications. , 2005, Current pharmaceutical design.

[84]  D. Craik,et al.  Insect peptides with improved protease‐resistance protect mice against bacterial infection , 2008, Protein science : a publication of the Protein Society.

[85]  C. Roumestand,et al.  Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation , 1996, FEBS letters.

[86]  S. Lovas,et al.  The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.

[87]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[88]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .

[89]  Dong-Kuk Lee,et al.  Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.

[90]  J. Fiddes,et al.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity , 1997, Antimicrobial agents and chemotherapy.

[91]  T. Ganz,et al.  Cathelicidins: a family of endogenous antimicrobial peptides , 2002, Current opinion in hematology.

[92]  K. Jeong,et al.  Effective antibacterial action of tat (47-58) by increased uptake into bacterial cells in the presence of trypsin. , 2008, Journal of microbiology and biotechnology.

[93]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[94]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[95]  R. Lehrer,et al.  Primate defensins , 2004, Nature Reviews Microbiology.

[96]  C. Rousselle,et al.  Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. , 2001, The Journal of pharmacology and experimental therapeutics.

[97]  B. Nordén,et al.  Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. , 2010, Biochimica et biophysica acta.

[98]  M. Morris,et al.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.

[99]  G. W. Vuister,et al.  A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency , 2009, The Journal of Biological Chemistry.

[100]  R. Fischer,et al.  Break on through to the Other Side—Biophysics and Cell Biology Shed Light on Cell‐Penetrating Peptides , 2005, Chembiochem : a European journal of chemical biology.

[101]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[102]  Jindrich Kopecek,et al.  Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.

[103]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[104]  S. Wölfl,et al.  Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity , 2009, Pharmaceuticals.

[105]  Ü. Langel,et al.  Cell-Penetrating Peptides , 2000, Methods in Molecular Biology.

[106]  E. Vivés,et al.  TAT peptide internalization: seeking the mechanism of entry. , 2003, Current protein & peptide science.

[107]  B. Lebleu,et al.  Cell penetrating peptides: overview and applications to the delivery of oligonucleotides , 2010, Cellular and Molecular Life Sciences.

[108]  B. Wiesner,et al.  Structural requirements for cellular uptake of α‐helical amphipathic peptides , 1999 .

[109]  F. Separovic,et al.  Membrane interactions of antimicrobial peptides from Australian frogs. , 2006, Biochimica et biophysica acta.

[110]  M. Morris,et al.  Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. , 2004, Biochemistry.

[111]  C. Contag,et al.  Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters , 2008, Proceedings of the National Academy of Sciences.

[112]  M. Hällbrink,et al.  Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects , 2006, Peptides.

[113]  A. Tossi,et al.  Amphipathic, alpha-helical antimicrobial peptides. , 2000, Biopolymers.

[114]  P. Tempst,et al.  Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera). , 1993, The Journal of biological chemistry.

[115]  Robert Bals,et al.  Antimicrobial Peptides , 2012, Drugs.

[116]  S. Yonehara,et al.  Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes* , 2003, The Journal of Biological Chemistry.

[117]  A. Pokorny,et al.  Mechanism and Kinetics of δ-Lysin Interaction with Phospholipid Vesicles† , 2002 .